GB CL SCC

GB CL SCC is a quantitative CL reagent for measuring SCCA in serum/plasma. Helps in detecting and monitoring squamous cell carcinomas like cervical and head-neck types with rapid 10-minute results.

PRODUCT DESCRIPTION

This in vitro diagnostic quantitative CL reagent uses the sandwich chemiluminescent immunoassay format to measure squamous cell carcinoma antigen (SCCA) in human serum or plasma. It requires 20 µL specimen and provides results in about 10 minutes. LoQ is 0.28 ng/mL. Stored at 2-8°C, avoid direct sunlight and freezing. TFDA certified. Useful for detection and monitoring of squamous cell carcinomas, including cervical and head & neck cancer types.

PERFORMANCE

Limit of Quantitation (LoQ): 0.28 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%

SPECIFICATION

PrincipleSandwich-type chemiluminescent immunoassay
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume20 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA

ORDERING INFORMATION

Catalogue No.Product
4ASCC02GB CL SCC
4ASCC1BGB CL SCC-Control
4ASCC2BGB CL SCC-Calibrator